Novo Nordisk's new CEO is set to face intense investor scrutiny this week as the Wegovy-maker shakes up its board and pursues ...
Due to the litigation Pfizer filed Friday and Monday against Metsera, Novo Nordisk and the biotech’s lead shareholder, CEO ...
Pfizer and Novo Nordisk are in a heated legal and bidding war over Metsera, an obesity drug developer. Novo's $10 billion bid ...
In a stunning twist, Novo Nordisk blindsides Pfizer in the obesity drug race--sparking one of pharma's boldest takeover ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback